Devices

The 25 most influential people in biopharma today

The anatomy of influence On Tuesday, GlaxoSmithKline's Andrew Witty kept two promises he had made to investors and the pharma industry. GSK completed its three-year review of its drug...

John Carroll Feb 7, 2012 3:16pm

The top 10 biotech deal terminations of 2011

Dec 19, 2011 8:11am

Autism poses drug R&D challenges, nonprofits upping therapeutics game

Aug 2, 2011 8:07am

Consumers want at-home medical devices, but are cautious over AI

Oct 16, 2025 6:58am

Encora names CEO as co-founder, and previous chief takes VP role

Oct 7, 2025 9:30am

Precision Neuroscience study explores 1st human BCI recipients

Oct 3, 2025 12:00pm